Evidence map›Paper›PMID 29441702›Full record

ArticleAdvanced healthcare materials2018

Tough Composite Hydrogels with High Loading and Local Release of Biological Drugs.

Jianyu Li, Eckhard Weber, Sabine Guth-Gundel, Michael Schuleit, Andreas Kuttler, Christine Halleux, Nathalie Accart, Arno Doelemeyer, Anne Basler, Bruno Tigani and 6 more

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Self-Adaptive Biomimetic Nanocomposite Hydrogel Orchestrates Dual-Targeting and On-Demand HAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Insulin-like growth factor-1 (IGF-1) empowering tendon regenerative therapies.Frontiers in bioengineering and biotechnology · 2025
    Review
  6. Review
  7. Review
  8. Materials today. Bio · 2024
    Review
  9. Article
  10. Drug Delivery Approaches to Improve Tendon Healing.Tissue engineering. Part B, Reviews · 2023
    Review
  11. Article
  12. Review
  13. Applications of functionally-adapted hydrogels in tendon repair.Frontiers in bioengineering and biotechnology · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Laponite-Based Nanomaterials for Drug Delivery.Advanced healthcare materials · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jianyu LiJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA.ORCID 0000-0002-1128-6804
Eckhard WeberNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Sabine Guth-GundelNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Michael SchuleitNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Andreas KuttlerNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Christine HalleuxNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Nathalie AccartNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Arno DoelemeyerNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Anne BaslerNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Bruno TiganiNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Kuno WuerschNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Mara FornaroNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Michaela KneisselNovartis Institutes for BioMedical Research, Fabrikstrasse 2, Novartis Campus, Basel, CH, 4056, Switzerland.
Alexander StaffordJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA.
Benjamin R FreedmanJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA.
David J MooneyJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA.

Funding

POLYMERIC MATRICES WITH DEFINED CELL ADHESION AND MECHANR01DE013033 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOONEY, DAVID J · 1998 to 2018
$3.0M
NIDCR NIH HHS R01 DE013033
6 · The paper itself

Abstract

Hydrogels are under active development for controlled drug delivery, but their clinical translation is limited by low drug loading capacity, deficiencies in mechanical toughness and storage stability, and poor control over the drug release that often results in burst release and short release duration. This work reports a design of composite clay hydrogels, which simultaneously achieve a spectrum of mechanical, storage, and drug loading/releasing properties to address the critical needs from translational perspectives. The clay nanoparticles provide large surface areas to adsorb biological drugs, and assemble into microparticles that are physically trapped within and toughen hydrogel networks. The composite hydrogels demonstrate feasibility of storage, and extended release of large quantities of an insulin-like growth factor-1 mimetic protein (8 mg mL

Indexed as

Achilles TendonBiomimetic MaterialsDrug CarriersHydrogelsInsulin-Like Growth Factor IPeptidesTendon InjuriesAnimalsDelayed-Action PreparationsFemaleHumansMiceNIH 3T3 CellsRatsRats, Sprague-DawleyDelayed-Action PreparationsDrug CarriersHydrogelsIGF1 protein, humanInsulin-Like Growth Factor IPeptidesbiological drugscomposite hydrogelscontrolled deliveryregenerative medicinetough hydrogels

Identifiers

PMID29441702
PMCPMC6192424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.